Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Growth rate of invasive ductal carcinomas from a screened 50-74-year-old population.

Autor: Otten JD; 1 Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., van Schoor G; 2 Department of Primary and Community Care, Radboud University Medical Center, Nijmegen, The Netherlands., Peer PG; 1 Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., den Heeten GJ; 3 Dutch Reference Centre for Screening, Nijmegen, The Netherlands.; 4 Department of Radiology, Biomechcanical Engineering & Physics, Academic Medical Centre Amsterdam, The Netherlands., Holland R; 5 Radboud University Medical Center, Nijmegen, The Netherlands., Broeders MJ; 1 Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; 3 Dutch Reference Centre for Screening, Nijmegen, The Netherlands., Verbeek AL; 1 Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

Publikováno v: Journal of medical screening [J Med Screen] 2018 Mar; Vol. 25 (1), pp. 40-46. Date of Electronic Publication: 2017 Jan 13.

Impact of chemotherapy on the outcome of osteosarcoma of the head and neck in adults.

Autor: Boon E; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., van der Graaf WT; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, United Kingdom., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Tesselaar ME; Department of Medical Oncology, Antoni van Leeuwenhoek Hospital/Netherlands Cancer Institute, Amsterdam, The Netherlands., van Es RJ; Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., Oosting SF; University of Groningen, Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands., de Bree R; Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands., van Meerten E; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands., Hoeben A; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands., Smeele LE; Department of Head and Neck Oncology and Surgery, Antoni van Leeuwenhoek Hospital/Netherlands Cancer Institute, Amsterdam, The Netherlands., Willems SM; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Witjes MJ; University of Groningen, Department of Oral and Maxillofacial Surgery, University Medical Center Groningen, Groningen, The Netherlands., Buter J; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands., Baatenburg de Jong RJ; Department of Otorhinolaryngology/Head and Neck Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands., Flucke UE; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Peer PG; Radboud Institute for Health Sciences, Biostatistics, Radboud University Medical Center, Nijmegen, The Netherlands., Bovée JV; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Van Herpen CM; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.

Publikováno v: Head & neck [Head Neck] 2017 Jan; Vol. 39 (1), pp. 140-146. Date of Electronic Publication: 2016 Aug 10.

In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium.

Autor: Lobbezoo DJ; GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht Department of Internal Medicine, Máxima Medical Center, Veldhoven., van Kampen RJ; GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht., Voogd AC; GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht Netherlands Comprehensive Cancer Organisation, Utrecht., Dercksen MW; Department of Internal Medicine, Máxima Medical Center, Veldhoven., van den Berkmortel F; Department of Internal Medicine, Atrium-Orbis Heerlen, Heerlen., Smilde TJ; Department of Medical Oncology, Jeroen Bosch Hospital, Den Bosch., van de Wouw AJ; Department of Internal Medicine, VieCuri Medical Center, Venlo., Peters FP; Department of Internal Medicine, Atrium-Orbis Sittard, Sittard., van Riel JM; Department of Internal Medicine, St Elisabeth Hospital, Tilburg., Peters NA; Department of Internal Medicine, St Jans Hospital, Weert., de Boer M; GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht., Peer PG; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Tjan-Heijnen VC; GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht vcg.tjan.heijnen@mumc.nl.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2016 Feb; Vol. 27 (2), pp. 256-62. Date of Electronic Publication: 2015 Nov 16.

Real-Life Use and Effectiveness of Adjuvant Trastuzumab in Early Breast Cancer Patients: A Study of the Southeast Netherlands Breast Cancer Consortium.

Autor: Seferina SC; Departments of Medical Oncology, Pathology, Clinical Epidemiology and Medical Technology Assessment, and Epidemiology and GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands; Department of Internal Medicine, Máxima Medical Centre, Veldhoven, The Netherlands; Department of Internal Medicine, Atrium Medical Centre Parkstad, Heerlen, The Netherlands; Department of Internal Medicine, Orbis Medical Centre, Sittard, The Netherlands; Department of Internal Medicine, VieCuri Medical Centre, Venlo, The Netherlands; Biostatistics, Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Lobbezoo DJ; Departments of Medical Oncology, Pathology, Clinical Epidemiology and Medical Technology Assessment, and Epidemiology and GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands; Department of Internal Medicine, Máxima Medical Centre, Veldhoven, The Netherlands; Department of Internal Medicine, Atrium Medical Centre Parkstad, Heerlen, The Netherlands; Department of Internal Medicine, Orbis Medical Centre, Sittard, The Netherlands; Department of Internal Medicine, VieCuri Medical Centre, Venlo, The Netherlands; Biostatistics, Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., de Boer M; Departments of Medical Oncology, Pathology, Clinical Epidemiology and Medical Technology Assessment, and Epidemiology and GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands; Department of Internal Medicine, Máxima Medical Centre, Veldhoven, The Netherlands; Department of Internal Medicine, Atrium Medical Centre Parkstad, Heerlen, The Netherlands; Department of Internal Medicine, Orbis Medical Centre, Sittard, The Netherlands; Department of Internal Medicine, VieCuri Medical Centre, Venlo, The Netherlands; Biostatistics, Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Dercksen MW; Departments of Medical Oncology, Pathology, Clinical Epidemiology and Medical Technology Assessment, and Epidemiology and GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands; Department of Internal Medicine, Máxima Medical Centre, Veldhoven, The Netherlands; Department of Internal Medicine, Atrium Medical Centre Parkstad, Heerlen, The Netherlands; Department of Internal Medicine, Orbis Medical Centre, Sittard, The Netherlands; Department of Internal Medicine, VieCuri Medical Centre, Venlo, The Netherlands; Biostatistics, Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., van den Berkmortel F; Departments of Medical Oncology, Pathology, Clinical Epidemiology and Medical Technology Assessment, and Epidemiology and GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands; Department of Internal Medicine, Máxima Medical Centre, Veldhoven, The Netherlands; Department of Internal Medicine, Atrium Medical Centre Parkstad, Heerlen, The Netherlands; Department of Internal Medicine, Orbis Medical Centre, Sittard, The Netherlands; Department of Internal Medicine, VieCuri Medical Centre, Venlo, The Netherlands; Biostatistics, Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., van Kampen RJ; Departments of Medical Oncology, Pathology, Clinical Epidemiology and Medical Technology Assessment, and Epidemiology and GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands; Department of Internal Medicine, Máxima Medical Centre, Veldhoven, The Netherlands; Department of Internal Medicine, Atrium Medical Centre Parkstad, Heerlen, The Netherlands; Department of Internal Medicine, Orbis Medical Centre, Sittard, The Netherlands; Department of Internal Medicine, VieCuri Medical Centre, Venlo, The Netherlands; Biostatistics, Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., van de Wouw AJ; Departments of Medical Oncology, Pathology, Clinical Epidemiology and Medical Technology Assessment, and Epidemiology and GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands; Department of Internal Medicine, Máxima Medical Centre, Veldhoven, The Netherlands; Department of Internal Medicine, Atrium Medical Centre Parkstad, Heerlen, The Netherlands; Department of Internal Medicine, Orbis Medical Centre, Sittard, The Netherlands; Department of Internal Medicine, VieCuri Medical Centre, Venlo, The Netherlands; Biostatistics, Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., de Vries B; Departments of Medical Oncology, Pathology, Clinical Epidemiology and Medical Technology Assessment, and Epidemiology and GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands; Department of Internal Medicine, Máxima Medical Centre, Veldhoven, The Netherlands; Department of Internal Medicine, Atrium Medical Centre Parkstad, Heerlen, The Netherlands; Department of Internal Medicine, Orbis Medical Centre, Sittard, The Netherlands; Department of Internal Medicine, VieCuri Medical Centre, Venlo, The Netherlands; Biostatistics, Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Joore MA; Departments of Medical Oncology, Pathology, Clinical Epidemiology and Medical Technology Assessment, and Epidemiology and GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands; Department of Internal Medicine, Máxima Medical Centre, Veldhoven, The Netherlands; Department of Internal Medicine, Atrium Medical Centre Parkstad, Heerlen, The Netherlands; Department of Internal Medicine, Orbis Medical Centre, Sittard, The Netherlands; Department of Internal Medicine, VieCuri Medical Centre, Venlo, The Netherlands; Biostatistics, Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Peer PG; Departments of Medical Oncology, Pathology, Clinical Epidemiology and Medical Technology Assessment, and Epidemiology and GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands; Department of Internal Medicine, Máxima Medical Centre, Veldhoven, The Netherlands; Department of Internal Medicine, Atrium Medical Centre Parkstad, Heerlen, The Netherlands; Department of Internal Medicine, Orbis Medical Centre, Sittard, The Netherlands; Department of Internal Medicine, VieCuri Medical Centre, Venlo, The Netherlands; Biostatistics, Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Voogd AC; Departments of Medical Oncology, Pathology, Clinical Epidemiology and Medical Technology Assessment, and Epidemiology and GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands; Department of Internal Medicine, Máxima Medical Centre, Veldhoven, The Netherlands; Department of Internal Medicine, Atrium Medical Centre Parkstad, Heerlen, The Netherlands; Department of Internal Medicine, Orbis Medical Centre, Sittard, The Netherlands; Department of Internal Medicine, VieCuri Medical Centre, Venlo, The Netherlands; Biostatistics, Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Tjan-Heijnen VC; Departments of Medical Oncology, Pathology, Clinical Epidemiology and Medical Technology Assessment, and Epidemiology and GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands; Department of Internal Medicine, Máxima Medical Centre, Veldhoven, The Netherlands; Department of Internal Medicine, Atrium Medical Centre Parkstad, Heerlen, The Netherlands; Department of Internal Medicine, Orbis Medical Centre, Sittard, The Netherlands; Department of Internal Medicine, VieCuri Medical Centre, Venlo, The Netherlands; Biostatistics, Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands vcg.tjan.heijnen@mumc.nl.

Publikováno v: The oncologist [Oncologist] 2015 Aug; Vol. 20 (8), pp. 856-63. Date of Electronic Publication: 2015 Jun 22.